Kim Byong bought LIPO
March 15, 2024 · Form 4 insider transaction
Kim Byong bought 25,000 shares of Lipella Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderKim Byong
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateMarch 15, 2024
Filing dateMarch 19, 2024
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo